Title: KAIST– Korea's largest bio-venture alliance makes its move.

Publication:  KAIST

Date: 10 June 2011

Summary

• LegoChem Bioscience (CEO Yong Zu Kim) was founded by major researchers who developed the Korea's first global medicine "FACTIVE" in LG Life Science.                                                         

• Since LG Life Science has been a leading pharmaceutical company, gathering of former LG researchers attracted the market's attention even before the foundation.

To view the full article (in Korean), click here ▶

About LegoChem Biosciences

LegoChem Biosciences, Inc. (LCB) is a research-based biotechnology company dedicated to discovering, developing, and commercializing innovative medicines by leveraging our chemistry expertise to make conventional biologics targeted and more potent for the benefit of patients with diseases of high unmet medical needs. We are advancing sustainable pipelines in therapeutic areas in antibiotics, anti-coagulants, oncology, antibody-drug conjugate (ADC), and protein-drug conjugate (PDC).